1. 1859 Clinical effects of prior chemotherapy on eribulin: Update and subgroup analysis of phase 2 multicenter single arm study of eribulin mesylate as first-line therapy for HER2 negative locally advanced or metastatic breast cancer. (September 2015) Authors: Nishimura, S.; Takashima, T.; Kawajiri, H.; Kashiwagi, S.; Noda, S.; Tokunaga, S.; Tei, S.; Yamagata, S.; Sunami, T.; Tezuka, K.; Ikeda, K.; Mizuyama, Y.; Ogawa, Y.; Onoda, N.; Nishimori, T.; Ishikawa, T.; Kudo, S.; Takada, M.; Hirakawa, K. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S285 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2824 Efficacy of B-raf and MEK inhibitor on human anaplastic thyroid cancer cell lines. (September 2015) Authors: Kurata, K.; Onoda, N.; Noda, S.; Kashiwagi, S.; Asano, Y.; Takashima, T.; Hirakawa, K. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S566 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. An exploratory phase II study of Eribulin re-challenge after short term therapy of 5-fuluorouracil for HER2-negative, advanced or recurrent breast cancer. (October 2020) Authors: Takashima, T.; Nishimura, S.; Kawajiri, H.; Mizuyama, Y.; Nishimori, T.; Yamagata, S.; Tokunaga, S.; Tezuka, K.; Tei, S.; Sunami, T.; Ikeda, K.; Ogawa, Y.; Kashiwagi, S.; Noda, S.; Onoda, N.; Ishikawa, T.; Kudoh, S.; Takada, M.; Hirakawa, K.; Ohira, M. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 1 Page Start: S62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. C‐Kit expression as a prognostic molecular marker in patients with basal‐like breast cancer. Issue 4 (14th January 2013) Authors: Kashiwagi, S.; Yashiro, M.; Takashima, T.; Aomatsu, N.; Kawajiri, H.; Ogawa, Y.; Onoda, N.; Ishikawa, T.; Wakasa, K.; Hirakawa, K. Journal: British journal of surgery Issue: Volume 100:Issue 4(2013:Apr.) Page Start: 490 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Tumour‐infiltrating CD8 to FOXP3 lymphocyte ratio in predicting treatment responses to neoadjuvant chemotherapy of aggressive breast cancer. Issue 7 (8th March 2016) Authors: Asano, Y.; Kashiwagi, S.; Goto, W.; Kurata, K.; Noda, S.; Takashima, T.; Onoda, N.; Tanaka, S.; Ohsawa, M.; Hirakawa, K. Journal: British journal of surgery Issue: Volume 103:Issue 7(2016) Page Start: 845 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗